Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: A 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway

American Journal of Kidney Diseases

Volumn 42, Issue 3, 2003, Pages 466-473

  Romundstad, Solfrid ^a   Holmen, Jostein ^b   Kvenild, Kurt ^b   Hallan, Hans ^b   Ellekjær, Hanne ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NONE

Author keywords

Follow up study; Microalbuminuria (MA); Mortality; Nondiabetic; Nonhypertensive

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MICROALBUMINURIA; MORTALITY; NORWAY; OUTCOMES RESEARCH; POPULATION RESEARCH; PROTEIN URINE LEVEL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 0042861401     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00742-X     Document Type: Article

References (24)

1. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
2. Messent JWC, Elliott TG, Hill RD, Jarrett RJO, Keen H, Viberti GC: Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study. Kidney Int 41:836-839, 1992
3. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J: A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16:996-1003, 1993
4. Dineen SF, Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview. Arch Intern Med 157:1413-1418, 1997
5. Spoelstra-de Man AME, Brouwer CB, Stehouwer CDA, Smulders YM: Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care 24:2097-2101, 2001
6. Ljungman S, Wikstrand J, Hartford M, Berglund G: Urinary albumin excretion - A predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 9:770-778, 1996
7. Bigazzi R, Bianchi S, Baldari D, Campese VM: Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 16:1325-1333, 1998
8. Jager A, Kostense PJ, Ruhé HG, et al: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects. Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 19:617-624, 1999
9. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K: Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35:898-903, 2000
10. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS: Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19:1992-1997, 1999
11. Roest M, Banga JD, Janssen WMT, et al: Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 103:3057-3061, 2001
12. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300:297-300, 1990
13. Gerstein HC, Mann JFE, Yi Q, et al: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421-426, 2001
14. Central Bureau of Statistics: Statistical Yearbook of Norway. Oslo, Kongsvinger, Norway. Statistical Yearbook of Norway, 1997
15. Midthjell K, Krüger Ø, Holmen J, et al: Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. Diabetes Care 22:1813-1820, 1999
16. Gatling W, Knight C, Mullee MA, Hill RD: Microalbuminuria in diabetes: A population study of prevalence and an assessment of three screening tests. Diabet Med 5:343-347, 1988
17. Pontremoli R, Sofia A, Ravera M, et al: Prevalence and clinical correlates of microalbuminuria in essential hypertension (The MAGIC study). Hypertension 30:1135-1143, 1997
18. Kleinbaum DG: Survival Analysis - A Self Learning Approach, New York, NY, Springer-Verlag, 1996
19. Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L: Cigarette smoking gives more respiratory symptoms among women than men. The Nord-Trøndelag Health Study. J Epidemiol Community Health 54:917-922, 2000
20. Gerber LM, Johnston K, Alderman MH: Assessment of a new dipstick test in screening for microalbuminuria in patients with hypertension. Am J Hypertens 11:1321-1327, 1998
21. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 39:S17-S31, 2002 (suppl 1)
22. Jensen JS, Clausen P, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B: Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. Nephrol Dial Transplant 12:S6-S9, 1997 (suppl 2)
23. Bakker AJ: Detection of microalbuminuria: Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 22:307-313, 1999
24. Central Bureau of Statistics: Statistical Yearbook of Norway. Oslo, Kongsvinger, Norway. Statistical Yearbook of Norway, 2000